Back to Search
Start Over
DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.
- Source :
-
Anti-cancer drug design [Anticancer Drug Des] 2000 Jun; Vol. 15 (3), pp. 191-201. - Publication Year :
- 2000
-
Abstract
- Cryptolepine and neocryptolepine are two indoloquinoline alkaloids isolated from the roots of the African plant Cryptolepis sanguinolenta. Both drugs have revealed antibacterial and antiparasitic activities and are strongly cytotoxic to tumour cells. We have recently shown that cryptolepine can intercalate into DNA and stimulates DNA cleavage by human topoisomerase II. In this study, we have investigated the mechanism of action and cytotoxicity of neocryptolepine, which differs from the parent isomer only by the orientation of the indole unit with respect to the quinoline moiety. The biochemical and physicochemical results presented here indicate that neocryptolepine also intercalates into DNA, preferentially at GC-rich sequences, but exhibits a reduced affinity for DNA compared with cryptolepine. The two alkaloids interfere with the catalytic activity of human topoisomerase II but the poisoning activity is slightly more pronounced with cryptolepine than with its isomer. The data provide a molecular basis to account for the reduced cytotoxicity of neocryptolepine compared with the parent drug.
- Subjects :
- Alkaloids metabolism
Animals
Antineoplastic Agents, Phytogenic metabolism
Cattle
Circular Dichroism
DNA drug effects
DNA metabolism
DNA Damage
DNA Footprinting
DNA Topoisomerases, Type II metabolism
Humans
Indole Alkaloids
Intercalating Agents metabolism
KB Cells
Melanoma, Experimental drug therapy
Mice
Mice, Inbred Strains
Plant Roots chemistry
Plants, Medicinal chemistry
Substrate Specificity
Alkaloids toxicity
Antineoplastic Agents, Phytogenic toxicity
Indoles
Intercalating Agents toxicity
Quinolines
Topoisomerase II Inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 0266-9536
- Volume :
- 15
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Anti-cancer drug design
- Publication Type :
- Academic Journal
- Accession number :
- 11049087